Waltz Comments on Extension of Moratoria on New Home Health Agencies in Six States
30 January 2018
Bloomberg BNA – Health Law Resource Center
Partner Judith Waltz is quoted in a BNA Health Care Policy Report article, “New Home Health Agencies in Six States? Medicare Still Says No,” about a decision by the Centers for Medicare & Medicaid Services to extend by six months a temporary moratorium on new home health agencies in six states.
Waltz said questions have been raised as to the effectiveness of blocking Medicare or Medicaid enrollment for an entire provider category, citing a ban on the enrollment of new clinical laboratories in California for several years, which industry stakeholders said had had an adverse impact on access to genetic testing for California patients.
“Moratoria also skew the market for existing providers who want to sell their entities as ongoing operations, since prospective providers can only get an enrollment with a continuing entity,” she said. Existing providers can also sell their practice for a premium under a moratorium, she added.
Metrics also are lacking for the moratoria, Waltz said, making it difficult to assess whether the program has been a success. “It’s impossible to tell if the moratoria really work because they are based on prevention and avoidance rather than recovery, so in essence it would require proving a negative to estimate the effectiveness,” she said.
Waltz said questions have been raised as to the effectiveness of blocking Medicare or Medicaid enrollment for an entire provider category, citing a ban on the enrollment of new clinical laboratories in California for several years, which industry stakeholders said had had an adverse impact on access to genetic testing for California patients.
“Moratoria also skew the market for existing providers who want to sell their entities as ongoing operations, since prospective providers can only get an enrollment with a continuing entity,” she said. Existing providers can also sell their practice for a premium under a moratorium, she added.
Metrics also are lacking for the moratoria, Waltz said, making it difficult to assess whether the program has been a success. “It’s impossible to tell if the moratoria really work because they are based on prevention and avoidance rather than recovery, so in essence it would require proving a negative to estimate the effectiveness,” she said.
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"